Outcomes4Me raises $4.7M for its AI-powered breast cancer care app

The free mobile app will better inform patients about treatment options and clinical trials

Screenshots of outcome4me app on a red and white background

Outcomes4Me, a free mobile app and platform for cancer patients to navigate cancer treatment and care, has raised $4.7 Million in a funding round led by Asset Management Ventures. Others participating in the funding round included  Sierra Ventures, Merstal Ltd. and the National Cancer Institute.

Outcomes4Me said it’ll use the funds to expand its reach to a larger number and variety of breast cancer patients.

“Outcomes4Me is the first commercially available app to offer all breast cancer patients a personalized evidence-based experience to help them navigate their care, irrespective of their geography or healthcare provider,” said Outcomes4Me.

The HIPAA-compliant app uses artificial intelligence (AI) and machine learning (ML) to analyze medical records and provide patients with actionable and timely information. 

The technology has already been applied to medical records from more than 700 institutions in the United States and Canada, giving organizations valuable insights into treatment protocols, clinical outcomes and patient-reported outcomes.

The app also provides access to various resources, including information previously targeting physicians only, such as the National Comprehensive Cancer Network Clinical (NCCN) Practice Guidelines and drug information from evidence-based clinical decision support provider UpToDate. 

Related Resource

Democratising AI for all: Transforming your operating model to support AI adoption

How to make the most of AI capabilities

Download now

"Being diagnosed with cancer can be stressful and overwhelming. Outcomes4Me is on a mission to support patients through this journey by empowering them with easy to understand, relevant and evidence-based information," said Maya R. Said, Sc. D., founder, president and CEO of Outcomes4Me. 

Said continued, "Patients are our highest priority as we strive to bring transparency between them and the medical field, using our continually evolving insights to improve care and accelerate research."

Additionally, Outcomes4Me announced that Sami Shalabi, who previously headed up engineering and product development at Google, has joined the team as chief operating officer.

“We want to continue making it simple for patients to navigate their care," Maya said. "Sami understands this goal and brings a product sophistication that I am confident will help evolve our product suite in ways that both our users and partners will love."

The Outcomes4Me app is available to users via the Apple App Store and Google Play.

Featured Resources

Next-generation time series: Forecasting for the real world, not the ideal world

Solve time series problems with AI

Free download

The future of productivity

Driving your business forward with Microsoft Office 365

Free download

How to plan for endpoint security against ever-evolving cyber threats

Safeguard your devices, data, and reputation

Free download

A quantitative comparison of UPS monitoring and servicing approaches across edge environments

Effective UPS fleet management

Free download

Recommended

NIH renews COVID research contract with Palantir
Cloud

NIH renews COVID research contract with Palantir

4 Oct 2021
Allurion launches remote patient weight-loss monitoring service
analytics

Allurion launches remote patient weight-loss monitoring service

21 Sep 2021
Sensome’s AI-powered stroke guidewire begins human trials in Australia
artificial intelligence (AI)

Sensome’s AI-powered stroke guidewire begins human trials in Australia

13 Sep 2021
Medigate and CrowdStrike bolster IoT medical device security
Internet of Things (IoT)

Medigate and CrowdStrike bolster IoT medical device security

10 Sep 2021

Most Popular

Best Linux distros 2021
operating systems

Best Linux distros 2021

11 Oct 2021
Apple MacBook Pro 15in vs Dell XPS 15: Clash of the titans
Laptops

Apple MacBook Pro 15in vs Dell XPS 15: Clash of the titans

11 Oct 2021
Cryptocurrency: Should you invest?
cryptocurrencies

Cryptocurrency: Should you invest?

27 Oct 2021